Doubts drawn on study that forms part of Chris Froome's asthma drug defence
A study conducted on dogs is a key part of Froome's defence has had doubts cast over it
Doubts have been raised about the research paper that Chris Froome is using to defend his high reading for an asthma drug in the 2017 Vuelta a España.
Team Sky's star tested over the allowed limit of asthma drug salbutamol after stage 18 on his way to winning the Vuelta overall in September. A judge should rule later this summer, possibly delivering Froome a ban and stripping his Vuelta a España title.
Froome and Team Sky have consistently denied any wrongdoing.
>>> Everything you need to know about Chris Froome’s salbutamol case
Froome, according to an article in May, is basing part of his defence on a published paper from the Centre for Human Drug Research in Leiden in the Netherlands. It recalibrated his reading from 2000 to 1429 nanograms per millilitre (ng/ml), much closer to the "actionable" threshold of 12.
It also said that WADA's salbutamol test is unsafe given that levels in urine can vary wildly. As many as 15.4 per cent of the tests can could produce false positives and putting the presumption of guilt on the athlete is "completely unacceptable."
The Daily Mail reported on Monday that the paper "is the subject of intense scrutiny" at the Union Cycliste Internationale (UCI) and that it simply could be a "delaying tactic" so that Froome can race for a fifth Tour de France in July. Also, the article pointed out that the Leiden research was carried out on dogs, not humans.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Another concern could be that one of the paper's authors Adam Cohen is the editor at the British Journal of Clinical Pharmacology and could have had a say when deciding to publish the findings. The Daily Mail article also raised the point that author Jules Heuberger argued in 2017 that EPO does not affect an athlete's performance.
The UCI's anti-doping lawyers are combing though the pages, around 1500, of submitted documents by Froome and his legal team. The included Leiden paper does not seem to bother WADA when considering its salbutamol testing model.
"I read the article you refer to and no, no concern at all," WADA's science director, Dr Olivier Rabin said last month. "Nothing new as their model is based on three well-known studies. We believe the current threshold is solid considering the scientific literature published on salbutamol over the past 20 years."
Rabin might have also looked at the impact score of the British Journal of Clinical Pharmacology. The article on Monday said that the ranking system for scientific publications lists it at 3.83. As an example, CA-A Cancer Journal For Clinicians has a 131.72 score.
Though some complain, Froome is free to race in the meantime due to the rules on specified or known substances that athletes take. Salbutamol is permitted, just that one cannot exceed a certain threshold.
Froome has already won the Giro d'Italia this season, and will be racing for a historic Giro/Tour double and fifth Tour title next month.
"It's difficult for ordinary people to understand," UCI boss David Lappartient said recently. "They say, 'What are they doing at the UCI? They do not move ahead with the case. Yes but this case is much more complex than others. And perhaps he has more means to demonstrate this complexity precisely, where others might have given up for not being able to carry out more cumbersome procedures."
Froome explained after his Giro win: "Once the time is right, we will share the information with everyone, and I am sure they will see it from our point of view."
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Gregor Brown is an experienced cycling journalist, based in Florence, Italy. He has covered races all over the world for over a decade - following the Giro, Tour de France, and every major race since 2006. His love of cycling began with freestyle and BMX, before the 1998 Tour de France led him to a deep appreciation of the road racing season.
-
Shimano Ultegra C60 wheelset review: fast rolling and great value, if a little heavy
The Ultegra C60 wheels share many similarities with the more expensive Dura-Ace model except for price and weight
By Andy Turner Published
-
The 16-year-old bike that's just won the British National Hill Climb championships
Rim brakes, no paint, tiny seat stays and a decade-old groupset are still plenty fast enough to help champion Harry Macfarlane see off some serious competition
By Joe Baker Published
-
'I never thought I'd really leave the team': Luke Rowe opens up on his reasons for departing Ineos Grenadiers
Welsh road captain is heading to Decathlon AG2R La Mondiale to become a sports director
By Adam Becket Published
-
Ineos Grenadiers announce 'highly motivated, hungry and ambitious' new performance structure for 2025
New sports directors, lead performance coach and head of performance support announced, among other changes
By Adam Becket Published
-
'I can help get the team back to where it was' - 20-year-old Artem Shmidt looks to the future after Ineos Grenadiers' disappointing season
Shmidt hoping to help revitalise team backed by Jim Ratcliffe after season of woes and as star rider Tom Pidcock gets set to move on
By Tom Thewlis Published
-
'I don’t think the people around Tom help' - Geraint Thomas on the Tom Pidcock and Ineos Grenadiers situation
Pidcock was "deselected" from Il Lombardia on Saturday, with the rider taking to Instagram to discuss decision
By Tom Thewlis Published
-
Tom Pidcock 'deselected' from Ineos Grenadiers squad for Il Lombardia
British rider says 'I guess off season starts early' in Instagram post
By Tom Davidson Published
-
Ineos Grenadiers have had their worst season ever, and the woes appear not to be over. What’s next for the super-team of a bygone era?
With Tom Pidcock possibly off to Q36.5 and Luke Rowe leaving, the news is not quiet around the British WorldTour squad
By Adam Becket Published
-
Remco Evenepoel puts transfer speculation to bed ahead of World Championships road race
'I'll stay where I am' says Double Olympic champion as he confirms he will remain at Soudal Quick-Step next season
By Tom Thewlis Published
-
'You can't sugarcoat it' - Luke Rowe says Ineos Grenadiers are 'underperforming'
British squad's experienced road captain believes his team has been "overtaken" by others
By Tom Davidson Published